Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-8-2
pubmed:abstractText
The long-term immunological benefit of protease inhibitor (PI)-sparing antiretroviral therapy (ART) using non-nucleoside reverse transcriptase inhibitors (NNRTIs) remains poorly investigated.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1359-6535
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
553-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17668564-Adult, pubmed-meshheading:17668564-Anti-HIV Agents, pubmed-meshheading:17668564-CD4 Lymphocyte Count, pubmed-meshheading:17668564-CD4-Positive T-Lymphocytes, pubmed-meshheading:17668564-CD8-Positive T-Lymphocytes, pubmed-meshheading:17668564-Drug Therapy, Combination, pubmed-meshheading:17668564-Female, pubmed-meshheading:17668564-HIV Antigens, pubmed-meshheading:17668564-HIV Infections, pubmed-meshheading:17668564-HIV Protease Inhibitors, pubmed-meshheading:17668564-HIV-1, pubmed-meshheading:17668564-Humans, pubmed-meshheading:17668564-Interferon-gamma, pubmed-meshheading:17668564-Lymphocyte Activation, pubmed-meshheading:17668564-Male, pubmed-meshheading:17668564-RNA, Viral, pubmed-meshheading:17668564-Reverse Transcriptase Inhibitors, pubmed-meshheading:17668564-T-Lymphocyte Subsets, pubmed-meshheading:17668564-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.
pubmed:affiliation
Laboratoire d'Immunologie Cellulaire, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't